• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌的动态对比增强磁共振成像:与形态学、肿瘤分期、组织学分级及前列腺特异抗原的相关性

Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA.

作者信息

Padhani A R, Gapinski C J, Macvicar D A, Parker G J, Suckling J, Revell P B, Leach M O, Dearnaley D P, Husband J E

机构信息

Academic Department of Radiology, Institute of Cancer Research, The Royal Marsden NHS Trust, Downs Road, Sutton, Surrey, SM2 5PT, U.K.

出版信息

Clin Radiol. 2000 Feb;55(2):99-109. doi: 10.1053/crad.1999.0327.

DOI:10.1053/crad.1999.0327
PMID:10657154
Abstract

AIM

To quantify MRI enhancement characteristics of normal and abnormal prostatic tissues and to correlate these with tumour stage, histological grade and tumour markers.

MATERIALS AND METHODS

Quantitative gradient recalled echo MR images were obtained following bolus injection of gadopentetate dimeglumine in 48 patients with prostate cancer. Turbo spin-echo T2-weighted images at the same anatomical position were reviewed for the presence of tumours (45 regions), normal peripheral zone (33 regions), and normal appearing central gland (30 regions). Time-signal intensity parameters (onset time, mean gradient and maximal amplitude of enhancement and wash-out score) and modelling parameters (permeability surface area product, lesion leakage space and maximum gadolinium concentration) were correlated with tumour stage, histological grade (Gleason score) and serum prostatic specific antigen (PSA) levels.

RESULTS

Significant differences were noted between peripheral zone and tumour with respect to signal intensity and modelling parameters (P = 0.0001), except onset time. No differences between central gland and tumour enhancement values were seen. There was weak correlation between MRI tumour stage and tumour vascular permeability (r(2) = 12%; P = 0.02) and maximum tumour gadolinium concentration (r(2) = 14%; P = 0.015). However, no significant correlations were seen with Gleason score or PSA levels.

CONCLUSION

Quantification of MR contrast enhancement characteristics allows tissue discrimination in prostate cancer consistent with known variations in microvessel density estimates.

摘要

目的

量化正常和异常前列腺组织的MRI增强特征,并将这些特征与肿瘤分期、组织学分级和肿瘤标志物相关联。

材料与方法

对48例前列腺癌患者静脉注射钆喷酸葡胺后获取定量梯度回波MR图像。回顾同一解剖位置的快速自旋回波T2加权图像,观察肿瘤(45个区域)、正常外周带(33个区域)和外观正常的中央腺体(30个区域)的情况。将时间-信号强度参数(起始时间、平均梯度、增强的最大幅度和廓清分数)和建模参数(通透表面积乘积、病变渗漏空间和最大钆浓度)与肿瘤分期、组织学分级(Gleason评分)和血清前列腺特异性抗原(PSA)水平相关联。

结果

除起始时间外,外周带和肿瘤在信号强度和建模参数方面存在显著差异(P = 0.0001)。中央腺体和肿瘤增强值之间未见差异。MRI肿瘤分期与肿瘤血管通透性(r(2) = 12%;P = 0.02)和最大肿瘤钆浓度(r(2) = 14%;P = 0.015)之间存在弱相关性。然而,与Gleason评分或PSA水平未见显著相关性。

结论

MR对比增强特征的量化能够在前列腺癌中实现组织鉴别,这与微血管密度估计的已知差异相符。

相似文献

1
Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA.前列腺癌的动态对比增强磁共振成像:与形态学、肿瘤分期、组织学分级及前列腺特异抗原的相关性
Clin Radiol. 2000 Feb;55(2):99-109. doi: 10.1053/crad.1999.0327.
2
Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.前列腺癌患者的血清胰岛素水平、疾病分期、前列腺特异性抗原(PSA)和 Gleason 评分。
Br J Cancer. 2002 Sep 23;87(7):726-8. doi: 10.1038/sj.bjc.6600526.
3
Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.使用动态对比增强反转准备双对比梯度回波序列通过定量灌注分析评估正常前列腺组织、慢性前列腺炎和前列腺癌。
Invest Radiol. 2008 Jul;43(7):481-7. doi: 10.1097/RLI.0b013e31816b2f63.
4
Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.利用动态对比增强磁共振成像鉴别前列腺癌与正常外周带及中央腺体组织。
Radiology. 2003 Oct;229(1):248-54. doi: 10.1148/radiol.2291020200. Epub 2003 Aug 27.
5
Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.直肠内磁共振成像(MRI)和磁共振波谱分析(MRS)在前列腺特异性抗原水平升高且既往活检阴性患者中对周围区肿瘤进行定位的价值。
Clin Radiol. 2008 Aug;63(8):871-9. doi: 10.1016/j.crad.2007.10.020.
6
[Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].[前列腺癌分期:直肠内磁共振成像、活检 Gleason 评分及术前前列腺特异性抗原水平联合信息的价值]
Rofo. 2006 Apr;178(4):385-90. doi: 10.1055/s-2006-926475.
7
Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.外照射放疗后复发性前列腺癌定位的动态对比增强磁共振成像
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):425-30. doi: 10.1016/j.ijrobp.2007.06.029. Epub 2007 Sep 19.
8
Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.在动物模型中前列腺癌与正常前列腺组织的鉴别:传统MRI和动态对比增强MRI
Rofo. 2005 Jul;177(7):935-9. doi: 10.1055/s-2005-858295.
9
Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.临床分期为T1c期前列腺癌患者病理分期的预测:新挑战
J Urol. 2002 Jul;168(1):100-4.
10
Dynamic contrast enhanced MRI in prostate cancer.前列腺癌的动态对比增强磁共振成像
Eur J Radiol. 2007 Sep;63(3):335-50. doi: 10.1016/j.ejrad.2007.06.028. Epub 2007 Aug 8.

引用本文的文献

1
Dynamic Contrast-Enhanced Study in the mpMRI of the Prostate-Unnecessary or Underutilised? A Narrative Review.前列腺磁共振成像中的动态对比增强研究——是否不必要或未得到充分利用?一项叙述性综述。
Diagnostics (Basel). 2023 Nov 20;13(22):3488. doi: 10.3390/diagnostics13223488.
2
Dynamic Contrast Enhanced Study in Multiparametric Examination of the Prostate-Can We Make Better Use of It?动态对比增强研究在前列腺多参数检查中的应用——我们能否更好地利用它?
Tomography. 2022 Jun 9;8(3):1509-1521. doi: 10.3390/tomography8030124.
3
Tissue clearing techniques for three-dimensional optical imaging of intact human prostate and correlations with multi-parametric MRI.
组织透明化技术用于完整人前列腺的三维光学成像及其与多参数 MRI 的相关性。
Prostate. 2021 Jun;81(9):521-529. doi: 10.1002/pros.24129. Epub 2021 Apr 20.
4
The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T relaxometry in patients with prostate cancer.钆基造影剂给药对前列腺癌患者基于磁共振指纹技术的 T 弛豫时间测定的影响。
Sci Rep. 2020 Nov 24;10(1):20475. doi: 10.1038/s41598-020-77331-4.
5
Design, Development, and Multi-Characterization of an Integrated Clinical Transrectal Ultrasound and Photoacoustic Device for Human Prostate Imaging.用于人体前列腺成像的集成临床经直肠超声和光声设备的设计、开发及多特性研究
Diagnostics (Basel). 2020 Aug 7;10(8):566. doi: 10.3390/diagnostics10080566.
6
Nasopharyngeal carcinoma perfusion MRI: Comparison of arterial spin labeling and dynamic contrast-enhanced MRI.鼻咽癌灌注磁共振成像:动脉自旋标记与动态对比增强磁共振成像的比较。
Medicine (Baltimore). 2020 May 29;99(22):e20503. doi: 10.1097/MD.0000000000020503.
7
Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection.经直肠超声造影在前列腺癌诊断中的应用
Urology. 2020 Apr;138:106-112. doi: 10.1016/j.urology.2019.12.025. Epub 2019 Dec 30.
8
Multiparametric MRI as a Biomarker of Response to Neoadjuvant Therapy for Localized Prostate Cancer-A Pilot Study.多参数 MRI 作为局部前列腺癌新辅助治疗反应的生物标志物:一项初步研究。
Acad Radiol. 2020 Oct;27(10):1432-1439. doi: 10.1016/j.acra.2019.10.017. Epub 2019 Dec 18.
9
Diagnostic Performance of Multiparametric MR Imaging at 3.0 Tesla in Discriminating Prostate Cancer from Prostatitis: A Histopathologic Correlation.3.0特斯拉多参数磁共振成像鉴别前列腺癌与前列腺炎的诊断效能:组织病理学相关性研究
Eurasian J Med. 2019 Feb;51(1):31-37. doi: 10.5152/eurasianjmed.2018.18195. Epub 2018 Nov 30.
10
Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer.动态对比增强磁共振成像(DCE-MRI)联合扩散加权成像(DWI)定量分析在前列腺癌诊断中的应用评估
Oncol Lett. 2019 Mar;17(3):3077-3084. doi: 10.3892/ol.2019.9988. Epub 2019 Jan 29.